Friday, February 20, 2015

EU Kicks Can on Greek Debt Down the Road -- Again

›
Eurozone finance ministers demonstrated their continued lack of resolve by kicking the can down the road – again: an agreement has been r...
Wednesday, February 18, 2015

Is Janet Yellen Too Chummy With Wall Street?

›
Is this bull market too dependent on "easy money" policies - QE? Could it be that the real reason that Fed Chairwoman Janet Y...
1 comment:
Friday, February 06, 2015

Is Carly Fiorina Accomplished Enough for a White House Run?

›
Former Hewlett-Packard (HPQ-$$37.95) CEO Carly Fiorina criticized preordained 2016 Democratic presidential contender Hillary Clinton ...
Tuesday, February 03, 2015

Energy Stocks Surge on Expected Bottoming in Crude Prices

›
Nordic American Offshore (NAO-$11.11) management has repeatedly stated that the fundamentals of its PSV (platform supply vessel) leasing...
Monday, February 02, 2015

Finding Opportunity in Crude Oil's Bust - Part 3

›
Natural Resource Partners LP (NRP-$9.39) is principally engaged in the business of owning and managing mineral reserve properties.  NRP ...

Finding Opportunity in Crude Oil's Bust - Part 2

›
Evolution Petroleum Corp. (EPM-$7.51) is an E&P specializing in lower cost secondary recovery efforts. Debt-Free Balance Sheet 2...
Sunday, February 01, 2015

Finding Opportunity in Crude Oil's Bust - Part 1

›
Though the Energy Information Administration (EIA) expects global oil inventories to continue to build in 2015, the downward pressure on ...
Wednesday, January 14, 2015

Calling Saudi Arabia's Oil Bluff

›
Saudi Oil Minister Ali al-Naimi keeps telling us that the world's top petroleum exporter is not going to cut production to prop up g...
2 comments:
Thursday, October 09, 2014

Price Transparency Benefits Hospital Patients

›
Internet access has ushered in an era of price transparency, where shoppers wielding smartphones check prices before deciding where to bu...
Monday, September 29, 2014

Watching Television for Allergy Relief

›
Looking to master the quiet sneeze or get relief from those itchy, watery eyes? If so, consider watching television, at least long enou...
Friday, September 26, 2014

Can Conatus Pharmaceuticals Duplicate Intercept's Success?

›
Conatus Pharmaceuticals (CNAT-$6.03) is developing a first-in-class, orally active pan-caspase protease inhibitor, called emricasan, which...
Monday, September 08, 2014

Keryx Biopharmaceutical's Kidney Drug Approved - What Now?

›
Keryx Biopharmaceuticals, Inc.   (KERX-$17.01) announced that the FDA approved Ferric Citrate (formerly known as Zerenex) for the contr...
Tuesday, August 19, 2014

PropThink Readers Profit from Amicus Therapeutics Buy Recommendation

›
Premium readers over at PropThink.com are already up 15% since our buy recommendation was issued on  Amicus Therapeutics [FOLD]  on Augu...
Tuesday, August 12, 2014

OncoGeneX Checkup

›
I gnore OncoGeneX’s (OGXI-$3.15) reported second-quarter 2014 loss of 47 cents per share. Investors, instead, should focus on existing...
Thursday, July 31, 2014

Making Sense on OncoGeneX

›
OncoGeneX’ s (OGXI - $2.98)  stock collapsed in the last four months, losing almost 80% in market value after reporting that its lead asse...
1 comment:
Wednesday, June 11, 2014

Conatus Pharma Breaks From Intercept's Shadow?

›
Bloggers and traders alike are scratching their heads, looking for answers as to why Conatus Pharmaceuticals (CNAT) is up more than 48%...
Friday, May 02, 2014

Agios Impresses With Leukemia Drug: Investor Beware

›
Agios Pharmaceuticals (AGIO-$43.35)   moved substantially higher in price last month after   reporting   Phase 1 data demonstrating that ...

Biotech Losers of 2013: AVEO, INFI, AFFY, and ARIA -- Where Are They Now?

›
Despite having lost more than 90% of its market valuation in the last 21 months, AVEO Pharma’s (AVEO-$1.24)  management believes it can d...